000 01227 a2200409 4500
005 20250511235339.0
264 0 _c19900814
008 199008s 0 0 eng d
022 _a0300-8126
024 7 _a10.1007/BF01642104
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHöffler, D
245 0 0 _aCefpodoxime proxetil in patients with endstage renal failure on hemodialysis.
_h[electronic resource]
260 _bInfection
_c
300 _a157-62 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBacterial Infections
_xblood
650 0 4 _aBiological Availability
650 0 4 _aCeftizoxime
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRenal Dialysis
650 0 4 _aTime Factors
650 0 4 _aCefpodoxime Proxetil
700 1 _aKoeppe, P
700 1 _aCorcilius, M
700 1 _aPrzyklinik, A
773 0 _tInfection
_gvol. 18
_gno. 3
_gp. 157-62
856 4 0 _uhttps://doi.org/10.1007/BF01642104
_zAvailable from publisher's website
999 _c2371538
_d2371538